MARKET

PHAT

PHAT

Phathom Pharmaceuticals, Inc.
NASDAQ
18.08
+1.71
+10.45%
After Hours: 15.85 -2.23 -12.33% 19:55 01/07 EST
OPEN
16.56
PREV CLOSE
16.37
HIGH
18.09
LOW
16.39
VOLUME
1.10M
TURNOVER
--
52 WEEK HIGH
18.31
52 WEEK LOW
2.210
MARKET CAP
1.29B
P/E (TTM)
-4.7423
1D
5D
1M
3M
1Y
5Y
1D
*Phathom Pharmaceuticals Plans to Use Proceeds for General Corporate Purposes >PHAT
Dow Jones · 38m ago
*Phathom Pharmaceuticals Announces Pricing of $130M Public Offering of Common Stock, Prefunded Warrants >PHAT
Dow Jones · 39m ago
*Phathom Pharmaceuticals Offering Is Expected to Close Around Jan. 9 >PHAT
Dow Jones · 39m ago
PHATHOM PHARMACEUTICALS INC - ANNOUNCES PRICING OF PUBLIC OFFERING OF 6.87M SHARES
Reuters · 41m ago
Stocks to Watch: Globus Medical, L3Harris, Phathom
Dow Jones · 4h ago
Closing Bell Movers: Defense stocks surge on Trump military budget comments
TipRanks · 4h ago
Phathom Shares Fall on Public Offering
Dow Jones · 4h ago
BUZZ-Phathom Pharmaceuticals drops after announcing planned equity raise
Reuters · 6h ago
More
About PHAT
Phathom Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases. The Company’s product candidates include VOQUEZNA, VOQUEZNA TRIPLE PAK, and VOQUEZNA DUAL PAK. Its product candidate, VOQUEZNA, contains vonoprazan, an oral small molecule potassium-competitive acid blocker, or potassium-competitive acid blocker (PCAB). PCABs are a novel class of medicines that block acid secretion in the stomach. Vonoprazan has also demonstrated clinical benefits in the treatment of erosive gastroesophageal reflux disease (erosive GERD), and in combination with antibiotics for the treatment of Helicobacter pylori (H. pylori) infection. GERD and H. pylori infection are two of the most common acid-related GI diseases. GERD is a disease that develops when the reflux of acidic stomach contents causes troublesome symptoms and/or complications. H. pylori is a bacterial pathogen.

Webull offers Phathom Pharmaceuticals Inc stock information, including NASDAQ: PHAT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PHAT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PHAT stock methods without spending real money on the virtual paper trading platform.